C44.49
Other specified malignant neoplasm of skin of scalp and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code C44.49 refers to a type of skin cancer categorized as a malignant neoplasm. Specifically, it describes cancers that develop on the skin of the scalp and neck, which do not fit into more specific categories. This classification helps healthcare providers document, diagnose, and manage these skin cancers effectively. Malignant neoplasms of the skin are serious conditions that require timely detection and treatment to prevent further health complications and improve outcomes.
Causes & Symptoms
Clinical Causes: Exposure to ultraviolet (UV) radiation from the sun or tanning beds Prolonged or repeated sunburns, especially during childhood Fair skin complexion, which is more susceptible to UV damage A history of skin injuries or chronic skin conditions Genetic predisposition, including family history of skin cancer Weakened immune system due to conditions or immunosuppressant medications Presence of certain environmental carcinogens or chemicals Age, with increased risk as individuals grow older
Key Symptoms: A new or changing skin lesion or sore that does not heal A persistent sore, ulcer, or lump on the scalp or neck A raised, firm bump with irregular edges Red, scaly patches or plaques that may ulcerate Changes in the pigmentation or color of the skin lesion Itching, bleeding, or crusting of the lesion Lump or thickening underneath the skin Possible pain or tenderness in the affected area
Diagnostic & Treatment
Diagnosis Path: - Additional tests may be performed to determine the extent or spread of the disease
Treatment Protocols: - Regular follow-up and skin examinations to monitor for recurrence or new lesions
Clinical Advice & FAQs
Billing Guidance
Is C44.49 a billable ICD-10 code?
Yes, C44.49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C44.49?
Clinical documentation must specify the nature of Other specified malignant neoplasm of skin of scalp and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
